We have previously shown that injection of mustard oil or glutamate into rat temporomandibular joint (TMJ) tissues, an experimental model of acute TMJ injury, can reflexly induce a prolonged increase in the activity of both digastric (jaw-opener) and masseter (jaw-closer) muscles. In this study, GABA was applied to the TMJ region by itself or in combination with glutamate, and the magnitude of evoked jaw muscle electromyographic (EMG) activity was measured. Application of GABA alone to the TMJ region did not evoke significant jaw muscle EMG activity when compared with normal saline controls. In contrast, co-application of GABA and glutamate into the TMJ region decreased the magnitude of glutamate-evoked EMG activity. This GABA-mediated inhibition of glutamate-evoked EMG activity followed an inverse dose-response relationship with an estimated median inhibitory dose (ID 50 ) of 0.17 Ϯ 0.05 (SE) mol and 0.031 Ϯ 0.006 mol for the digastric and masseter muscles, respectively. Co-administration of the GABA A receptor antagonist bicuculline (0.05 mol) but not the GABA B receptor antagonist phaclofen (0.05 or 0.15 mol) reversed the suppressive actions of GABA, indicating that this action of GABA may be mediated by peripheral GABA A receptors located within the TMJ region. Our results suggest that activation of peripheral GABA A receptors located within the TMJ region could act to decrease the transmission of nociceptive information.
I N T R O D U C T I O N
Activation of either peripheral excitatory amino acid (EAA) or GABA A receptors located in cutaneous tissues of the tail of neonatal rats evokes a nociceptive reflex Hildebrand 1993, 1994) . Injection of glutamate into the temporomandibular joint (TMJ) region also reflexly induces a prolonged increase in the electromyographic (EMG) activity of both digastric and masseter muscles in adult rats ). This effect of glutamate is mediated through activation of peripheral EAA receptors located within the TMJ region because coapplication of both N-methyl-D-aspartate (NMDA)-and non-NMDA-receptor antagonists significantly reduces the magnitude of glutamate-evoked jaw muscle EMG activity. However, it is not clear whether there are also peripheral GABA receptors within the TMJ region or if application of GABA to the TMJ region of adult rats can evoke jaw muscle activity in a manner that is analogous to glutamate. Consequently, this study was undertaken to investigate the effects of GABA application to the TMJ region on jaw muscle EMG activity.
M E T H O D S

Surgical preparation
Forty-eight male Sprague-Dawley rats (250 -450 g) were prepared for acute recording of jaw muscle EMG activity as previously described . Briefly, under surgical anesthesia (O 2 : 0.3-0.4 l/min; N 2 O: 0.6 -0.7 l/min; halothane: 1.5-2%) a tracheal cannula was inserted, and the left femoral vein was cannulated, bipolar electrodes were inserted bilaterally into the digastric and masseter muscles, and a catheter was carefully inserted into the TMJ region and used to apply different chemicals. After surgery, the level of halothane was maintained at 0.8 -1% for the duration of the experiment. All surgeries and procedures were approved by the University of Toronto Animal Care Committee in accordance with the regulations of the Ontario Animal Research Act (Canada). At the end of each experiment, rats were euthanized with T61 (Hoechst).
Drug solutions
The following chemicals were employed: glutamate, GABA, the GABA A receptor antagonist bicuculline and the GABA B receptor antagonist phaclofen (Research Biochemicals International; Natick, MA). All drugs were dissolved in isotonic saline, and the resulting solutions were adjusted to a pH of ϳ7. Solutions (total volume per injection: 10 L) were injected bilaterally into the TMJ capsule . Intravenous administration of GABA (5 mol in 0.1 ml normal saline) also was made through the femoral vein catheter.
Stimulation and recording
EMG activity was amplified (gain: 500ϫ; bandwidth 30 -1,000 Hz) and fed into a computer equipped with a CED 1401 Plus board and analysis software (Spike 2, Cambridge Electronics). EMG activity was recorded continuously for the duration of each experiment. Baseline EMG activity was observed for 10 min, and then glutamate (2.5 mol) was injected into the TMJ region over 5 s. We previously demonstrated that application of this dose of glutamate to the TMJ region evokes EMG activity in both the ipsilateral digastric and masseter muscles by a reflex pathway through the trigeminal subnucleus caudalis . Thirty minutes after the initial glutamate injection either glutamate (2.5 mol) alone, GABA (0.005, 0.05, 0.5 or 5 mol) alone, GABA in combination with glutamate, or GABA in combination with glutamate and either the selective GABA receptor antagonists bicuculline (0.05 mol) or phaclofen (0.05 or 0.15 mol) were injected into the TMJ region. All drugs were at room temperature immediately before injection. Osmolarity was adjusted by the addition of sodium chloride.
Data analysis
Recorded EMG data were rectified off-line, and EMG area bins (V-min) were calculated. Mean baseline EMG activity was sub-
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tracted from each EMG area bin to yield residual EMG area bins. The area under the EMG response curve (AUC) was calculated by summing all residual EMG area bins greater than two times the SD of the mean baseline. The relative EMG response was then calculated by normalizing the AUC for the second application (AUC 2 ) to the AUC evoked by glutamate (AUC 1 ). For each dosing regimen, a mean relative EMG response was determined from the average of five experiments conducted in three rats.
To calculate ID 50 , nonlinear regression analysis was performed on the dose-response curve for GABA-mediated suppression of glutamate-evoked EMG activity according to the equation
Comparisons of relative EMG responses were made with the use of analysis of variance (ANOVA) on ranks because the variances were always heterogeneous. Significant differences in the ID 50 were determined with a Student's t-test.
R E S U L T S Glutamate (2.5 mol), GABA, or normal saline was injected into the TMJ region 30 min after an initial injection of glutamate (2.5 mol) was applied. Repeated application of glutamate at an interval of 30 min evoked EMG responses in both ipsilateral jaw muscles (Fig. 1A) that were of comparable magnitude, in agreement with previous findings . In contrast, the EMG activity evoked by GABA at all the doses applied (5, 0.5, 0.05, and 0.005 mol) was significantly less than that evoked by glutamate and similar to that evoked by normal saline (P Ͻ 0.05 Kruskal-Wallis one-way ANOVA on Ranks, Dunn's method, Fig. 1, B and C) .
The jaw muscle activity evoked by application of glutamate alone to the TMJ region was compared with that evoked by co-application of glutamate and GABA (5, 0.5, 0.05, or 0.005 mol) or after systemic administration of GABA (5 mol). Systemic administration of GABA (5 mol) had no effect on glutamate-evoked EMG activity ( Fig. 2A) , but local application of GABA to the TMJ region suppressed glutamate-evoked EMG activity in a dose-dependent manner with an estimated mean (ϮSE) ID 50 of 0.17 Ϯ 0.05 mol and 0.031 Ϯ 0.006 mol for the digastric and masseter muscles, respectively (Figs. 2 and 3) . The ID 50 for the digastric muscle was significantly larger than the ID 50 for the masseter muscle (P Ͻ 0.05,
Student's t-test).
Co-application of bicuculline (0.05 mol) but not phaclofen (0.05 or 0.15 mol) partially attenuated GABA-mediated suppression of glutamate-evoked EMG activity (Fig. 2, C and D) . Co-application of bicuculline also resulted in a rightward shift of the dose-response curves of GABA-mediated suppression for both the digastric and masseter muscles; the estimated ID 50 values increased to 7.5 Ϯ 1.5 mol and 1.5 Ϯ 0.9 mol for the digastric and masseter muscles, respectively (P Ͻ 0.05, Student's t-test; Fig. 3 ).
D I S C U S S I O N
Before this study it was not known whether peripheral GABA receptors exist within the TMJ region of adult rats or if activation of these receptors evokes jaw muscle activity analogous to that evoked by glutamate. In this study it was shown that when compared with glutamate local application of GABA to the TMJ region was not effective in evoking jaw muscle activity. However, TMJ application of GABA was found to inhibit glutamate-evoked jaw muscle EMG activity, and this GABA-mediated inhibition was reversed by co-application of the GABA A receptor antagonist bicuculline but not by the GABA B receptor antagonist phaclofen. These results suggest that GABA A receptors are located within the TMJ region and that their activation appears to attenuate the nociceptive reflex response that can be evoked from this region. In contrast, GABA application to the tail skin of the neonatal rat isolated spinal cord-tail preparation evokes a nociceptive reflex (Ault and Hildebrand 1994) . This difference may reflect the use of an in vitro neonatal as opposed to an in vivo adult rat preparation and/or differences between cutaneous versus deep tissues.
Previous reports indicated that application of GABA to peripheral nerves has two effects. 1) It depolarizes certain nerve fibers, and 2) it concomitantly suppresses the conduction of sensory information along small-diameter (A␦, C) primary afferent fibers that can convey nociceptive information from the periphery to the CNS (Brown and Marsh 1978; Bhisitkul et al. 1987; Morris et al. 1983) . GABA-induced depolarization of peripheral nerve fibers is attenuated by GABA A receptor antagonists and mediated through the opening of chloride channels (Brown and Marsh 1978; Desarmenien et al. 1984; Deschenes et al. 1976; Gallagher et al. 1978; Morris et al. 1983) . GABA-mediated activation of chloride channels may also act as a shunt, allowing current to flow out across the axon membrane instead along the nerve fiber and thus impede action potential conduction (Wall 1995) .
The rat TMJ region is innervated almost exclusively by A␦ and C fibers (Kido et al. 1995) , and there is recent evidence that suggests that GABA may block action potential conduction through small-diameter trigeminal primary afferents (Soja et al. 1998) . We speculate that activation of peripheral GABA A channels located on the unmyelinated terminal segments of TMJ afferent fibers results in a current shunt that interferes with the conduction of action potentials (Brown and Marsh 1978; Wall 1995) .
GABA is distributed widely in nonneural tissues and may also be synthesized and released by a subpopulation of trigeminal primary afferent fibers, providing evidence in favor of a modulatory role for GABA in the peripheral nervous system (Szabat et al. 1992; Tanaka 1985) . Our findings also raise the possibility that activation of peripheral GABA A receptors within the TMJ region may result in a local analgesic effect, and so further study of these mechanisms may prove to have clinical significance in pain management.
